Summary & Overview
HCPCS S9430: Pharmacy Compounding and Dispensing Services
HCPCS Level II code S9430 denotes pharmacy compounding and dispensing services, covering preparation and provision of customized medications. This code captures pharmacist activities related to creating patient-specific formulations and dispensing compounded products that are not available as commercially manufactured drugs. Nationally, compounding and dispensing services are an important component of medication access for patients with unique dosing, allergy, or formulation needs.
Key payers referenced in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of coverage patterns, common billing practices tied to compounding services, and how S9430 is positioned within pharmacy service lines. The publication summarizes typical sites of service, explains when S9430 is used in clinical workflows, and identifies common modifier usage and payer considerations where available.
This summary provides actionable context for coding, billing teams, and policy analysts seeking clarity on where S9430 fits in pharmacy service bundles and reimbursement pathways. Data not available in the input for specific associated taxonomies, ICD-10 diagnoses, related codes, and payer-specific policy details is noted where relevant.
Billing Code Overview
HCPCS Level II code S9430 represents pharmacy compounding and dispensing services. The service type is pharmacy compounding and dispensing, involving preparation, customization, and provision of medications tailored to specific patient needs. The typical site of service for S9430 is pharmacy settings, including hospital outpatient pharmacies, retail/community pharmacies, and specialty pharmacies where compounding and dispensing activities occur.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A patient with a chronic dermatologic condition (for example severe eczema or psoriasis) presents to a retail or specialty pharmacy with a prescription for a customized topical formulation that is not commercially available. The prescriber orders a compounded topical steroid/antibiotic/emollient preparation to a specific concentration and vehicle for targeted site application over a 30‑day supply.
The clinical workflow: the prescriber sends a written or electronic prescription specifying ingredients, concentrations, dosage form, and directions. The pharmacist reviews the prescription for safety, verifies allergies and drug interactions, performs compounding per USP <795>/<797> or state board standards, documents lot numbers and beyond‑use dating, dispenses the product with counseling, and bills pharmacy compounding and dispensing services using S9430. Medication administration occurs at home by the patient with documented patient education and follow up arranged with the prescriber for effectiveness and adverse effects.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when compounding required substantially greater resources or complexity than typical (e.g., complex calculations, multiple active ingredients, extensive stability testing documentation). |